We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+0.84%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$9.62B
AUM Growth
+$482M
(+5.3%)
Cap. Flow
+$328M
Cap. Flow
% of AUM
3.41%
Top 10 Holdings %
Top 10 Hldgs %
35.81%
Holding
1,132
New
163
Increased
147
Reduced
109
Closed
164
Avg Time Held Equity + Options
2.6
quarters
Top 10 Avg Time Held Equity + Options
0.5
quarters
Top 20 Avg Time Held Equity + Options
0.6
quarters
Avg Time Held Equity only
2.6
quarters
Top 10 Avg Time Held Equity only
0.5
quarters
Top 20 Avg Time Held Equity only
0.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACC
American Campus Communities, Inc.
ACC
|
+$454M |
| 2 |
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
|
+$312M |
| 3 |
CDK
CDK Global, Inc.
CDK
|
+$286M |
| 4 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$248M |
| 5 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$220M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$829M |
| 2 |
MIME
Mimecast Limited
MIME
|
+$351M |
| 3 |
PLAN
Anaplan, Inc.
PLAN
|
+$325M |
| 4 |
MGP
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
|
+$260M |
| 5 |
VNE
Veoneer, Inc.
VNE
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.77% |
| 2 | Financials | 20.95% |
| 3 | Industrials | 11.05% |
| 4 | Real Estate | 10.82% |
| 5 | Healthcare | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
751
PUT
Norwegian Cruise Line
NCLH
$7.07B
| $933K | 0.01% |
69,200
| – | – |
2021 Q2
4 quarters
|
|
752
PUT
Tenet Healthcare
THC
$21.7B
| $931K | 0.01% |
113,100
+11,200
| +11% | +$779K |
2021 Q4
2 quarters
|
|
753
So-Young International
SY
$257M
| $922K | 0.01% |
+1,076,000
| New | +$1.35M |
2022 Q2
0 quarters
|
|
754
American Tower
AMT
$84.7B
| $898K | 0.01% |
+3,515
| New | +$882K |
2022 Q2
0 quarters
|
|
|
SPNE
755
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $859K | 0.01% |
152,083
+37,683
| +33% | +$328K |
2022 Q1
1 quarter
|
|
756
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $858K | 0.01% |
39,534
+4,534
| +13% | +$127K |
2022 Q1
1 quarter
|
|
757
Icon
ICLR
$12.7B
| $826K | 0.01% |
+3,810
| New | +$854K |
2022 Q2
0 quarters
|
|
758
EQT Corp
EQT
$33.3B
| $824K | 0.01% |
23,961
-44,390
| -65% | -$1.83M |
2021 Q3
3 quarters
|
|
759
DELISTED
Inozyme Pharma
INZY
| $817K | 0.01% |
+171,347
| New | +$745K |
2022 Q2
0 quarters
|
|
760
Immunic
IMUX
$109M
| $807K | 0.01% |
23,259
+13,259
| +133% | +$850K |
2022 Q1
1 quarter
|
|
761
VICI Properties
VICI
$25.3B
| $803K | 0.01% |
26,952
-96,023
| -78% | -$2.83M |
2018 Q3
15 quarters
|
|
762
Canadian Pacific Kansas City
CP
$75.2B
| $786K | 0.01% |
+11,257
| New | +$815K |
2022 Q2
0 quarters
|
|
763
Sociedad Química y Minera de Chile
SQM
$17.8B
| $761K | 0.01% |
+9,107
| New | +$801K |
2022 Q2
0 quarters
|
|
764
Penumbra
PEN
$12.6B
| $748K | 0.01% |
6,007
+3,459
| +136% | +$549K |
2022 Q1
1 quarter
|
|
|
CSII
765
DELISTED
Cardiovascular Systems, Inc.
CSII
| $724K | 0.01% |
50,403
-9,597
| -16% | -$167K |
2022 Q1
1 quarter
|
|
766
PUT
DELISTED
Redfin
RDFN
| $711K | 0.01% |
60,000
| – | – |
2022 Q1
1 quarter
|
|
767
PUT
Expedia Group
EXPE
$32.4B
| $705K | 0.01% |
+13,500
| New | +$1.91M |
2022 Q2
0 quarters
|
|
768
Precision BioSciences
DTIL
$180M
| $704K | 0.01% |
+14,667
| New | +$861K |
2022 Q2
0 quarters
|
|
769
M/I Homes
MHO
$3.21B
| $701K | 0.01% |
+17,675
| New | +$768K |
2022 Q2
0 quarters
|
|
|
LFG
770
DELISTED
Archaea Energy Inc.
LFG
| $692K | 0.01% |
44,534
-116,561
| -72% | -$2.36M |
2021 Q3
3 quarters
|
|
771
California Resources
CRC
$4.77B
| $690K | 0.01% |
17,922
-13,559
| -43% | -$581K |
2020 Q4
6 quarters
|
|
|
RXDX
772
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $678K | 0.01% |
+24,000
| New | +$696K |
2022 Q2
0 quarters
|
|
|
ORTX
773
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $639K | 0.01% |
109,392
-15,510
| -12% | -$87.5K |
2022 Q1
1 quarter
|
|
774
Scholar Rock
SRRK
$5.09B
| $631K | 0.01% |
+115,000
| New | +$826K |
2022 Q2
0 quarters
|
|
775
PUT
Ford
F
$47.8B
| $628K | 0.01% |
+423,500
| New | +$5.8M |
2022 Q2
0 quarters
|
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q2 2022 Portfolio in Review
As of Q2 2022, UBS O'Connor held 1,132 positions worth $9.62B, up 5.3% from $9.14B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
UBS O'Connor deployed $328M of net new capital in Q2 2022, opening 163 new positions and adding to 147 existing holdings. Its largest new stake was American Campus Communities, Inc.: 7,174,697 shares worth $463M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Occidental Petroleum Corp Warrants, an estimated $15.7M trimmed.
- UBS O'Connor's largest Q2 2022 buy was American Campus Communities, Inc.: 7,174,697 shares worth $463M.
- UBS O'Connor added most to Mandiant, Inc. Common Stock in Q2 2022, an estimated $220M increase.
- UBS O'Connor's biggest Q2 2022 reduction was Occidental Petroleum Corp Warrants, cutting an estimated $15.7M.
- UBS O'Connor fully exited Cerner Corp in Q2 2022, selling an estimated $829M.
- UBS O'Connor's ten largest holdings make up 36% of its $9.62B portfolio in Q2 2022.
- UBS O'Connor opened 163 new positions and closed 164 in Q2 2022.
- UBS O'Connor's portfolio value rose 5.3% quarter-over-quarter to $9.62B.
Based on UBS O'Connor's 13F filing for Q2 2022, filed 12 Aug 2022.